MedHQ, a leading provider of human resources and financial management services to healthcare providers across the country, announced today the acquisition of national staffing agency, Becker Health, a leading provider of specialty nursing and allied talent acquisition solutions for the health care industry. Together, MedHQ and Becker Health will provide […]
Featured News
Wellness healthcare launch online pharma market place
Wellness Healthcare Group has launched Pharmacentre, the first online marketplace for pharma commerce. Pharmacentre is an online platform that enables licensed medical professionals to sell quality medical products to businesses and consumers alike. As an integrative marketplace, Pharmacenter integrates consumer-facing business to consumer selling and provider-facing business to business selling […]
Synergy Health Partners Acquires SoCal Anesthesia Solutions, Inc.
Synergy Health Partners, a leading hospital services company that improves access to patient care through innovative and custom orthopedic and general surgeon staffing programs, today announced the acquisition of SoCal Anesthesia Solutions, Inc. Terms of the deal were not disclosed. Founded three years ago by Dr. Jay Rindenau, a 25-year […]
Bethesda Health Care taps Microsoft for PAS
The cloud platform will be rolled out in its new mental health clinic in Western Australia. Bethesda Health Care, a private healthcare provider in Western Australia, will be the first medical facility in Australia to implement the latest Microsoft Cloud for Healthcare as its patient administration system. According to a […]
Asahi Kasei Medical to Acquire Bionova Scientific, U.S.-based Biopharmaceutical CDMO
Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies, especially those developing next-generation antibody based drugs*. One of the Asahi Kasei Group’s growth […]
GP PRO, APIC Announce Strategic Partnership
GP PRO, a division of Georgia-Pacific helping to advance hygiene in healthcare and a wide range of other market segments, announced that it is a 2022 Strategic Partner of the Association for Professionals in Infection Prevention and Epidemiology (APIC). The partnership affords GP PRO the opportunity to establish long-term relationships […]
GoodRx Closes Acquisition of vitaCare, A Tech-Enabled Pharmacy Services Platform
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering […]
Northwestern Medicine and Medallia Co-Develop Solution to Help Healthcare Organizations Maintain Magnet Designation
-Medallia, Inc., the global leader in customer and employee experience, and Northwestern Medicine announced they have co-developed a new Medallia Magnet Solution to automate the Magnet survey administration and reporting requirements while providing hospitals with actionable insights to help improve patient experience. Magnet, an accreditation program developed by the American […]
Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative
Daewoong Pharmaceutical and HanAll Biopharma invest in the broad potential of Turn Biotechnologies Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases Daewoong Pharmaceutical and HanAll Biopharma today announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a […]
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab
Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that it has entered into a licence agreement with Eli Lilly and Company (“Lilly”) under which Telix is granted exclusive worldwide rights to develop and commercialise radiolabelled forms of Lilly’s olaratumab antibody for the diagnosis and treatment of human cancers. […]
